Y lo mismo ocurri con Victoza, otro antidiabtico de la familia de las liraglutinas, recuerda
In people with T2D and overweight/obesity, 16 weeks of danuglipron led to a placebo-adjusted WL up to 4.2 kg with the highest dose of 120 mg twice daily
Tracking your GLP-1 journey across different medication sources presents a challenge: determining whether changes in side effects, hunger levels, or weight loss stem from the medication itself, dose adjustments, or formulation differences
Youre not deceiving, youre curating. Youre not lying, youre managing your image. Youre not manipulating, youre editing for aesthetic cohesion. But when the curation is paired with undisclosed AI and monetized through a financial stake in a health-tech company, it crosses into ethically indefensible territory
However, the evidence is currently limited by the small number of available studies, particularly regarding symptomatic outcomes such as pain and function
X.BorelJ